Synthesis of novel pyrazole analogues as efficacious antimicrobial agents

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 3, Issue SUPPL. 5, 2011, Pages 166-176

  Chauhan, Alka ^a   Sharma, P K ^a   Kaushik, Niranjan ^a   Kumar, Nitin ^a  

^a MEERUT INSTITUTE OF ENGINEERING AND TECHNOLOGY   (India)

Author keywords

Antibacterial activity; Antifungal activity; Chalcone; Pyrazole

Indexed keywords

(2E) 1,3 DIPHENYLPROP 2 EN 1 ONE; 3 PHENYL 5(3,4,5 TRIMETHOXYPHENYL) 1H PYRAZOLE 1 CARBOTHIOAMIDE; 3(2,4 DICHLOROPHENYL) 5(3 HYDROXYPHENYL) 1H PYRAZOLE 1 CARBOTHIOAMIDE; 3(2,4 DICHLOROPHENYL) 5(3,4,5 TRIMETHOXYPHENYL) 1H PYRAZOLE 1 CARBOTHIOAMIDE; 3(2,4 DIMETHOXYPHENYL) 5(2 NITROPHENYL) 1H PYRAZOLE 1 CARBOTHIOAMIDE; 3(2,5 DICHLOROPHENYL) 5 PHENYL 1H PYRAZOLE 1 CARBOTHIOAMIDE; 3(3 AMINOPHENYL) 5 PHENYL 1H PYRAZOLE 1 CARBOTHIOAMIDE; 3(3 AMINOPHENYL) 5(3 NITROPHENYL) 1H PYRAZOLE 1 CARBOTHIOAMIDE; 3,5 DIPHENYL 4,5 DIHYDRO 1H PYRAZOLE 1 CARBOTHIOAMIDE; 3,5 DIPHENYL 4,5 DIHYDRO 1H PYRAZOLE 1 CARBOTHIOAMIDE DERIVATIVE; 5(2 METHOXYPHENYL) 3 PHENYL 4,5 DIHYDRO 1H PYRAZOLE 1 CARBOTHIOAMIDE; 5(2 NITROPHENYL) 3 PHENYL 1H PYRAZOLE 1 CARBOTHIOAMIDE; 5(2,4 DICHLOROPHENYL) 3 PHENYL 1H PYRAZOLE 1 CARBOTHIOAMIDE; 5(2,4 DICHLOROPHENYL) 3(2 METHOXYPHENYL) 1H PYRAZOLE 1 CARBOTHIOAMIDE; 5(2,4 DIMETHOXYPHENYL) 3 PHENYL 4,5 DIHYDRO 1H PYRAZOLE 1 CARBOTHIOAMIDE; 5(3 AMINOPHENYL) 3 PHENYL 1H PYRAZOLE 1 CARBOTHIOAMIDE; 5(3 AMINOPHENYL) 3(2,5 DICHLOROPHENYL) 1H PYRAZOLE 1 CARBOTHIOAMIDE; 5(3 HYDROXYPHENYL) 3 PHENYL 1H PYRAZOLE 1 CARBOTHIOAMIDE; 5(4 BROMOPHENYL) 3 PHENYL 1H PYRAZOLE 1 CARBOTHIOAMIDE; 5(4 CHLOROPHENYL) 3 PHENYL 1H PYRAZOLE 1 CARBOTHIOAMIDE; 5(4 METHOXYPHENYL) 3 PHENYL 1H PYRAZOLE 1 CARBOTHIOAMIDE; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; CHALCONE DERIVATIVE; KETOCONAZOLE; OFLOXACIN; PHENYL (3 PHENYLOXIRAN 2 YL) METHANONE; PYRAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS NIGER; CONTROLLED STUDY; DRUG EFFICACY; DRUG STRUCTURE; DRUG SYNTHESIS; ESCHERICHIA COLI; MASS SPECTROMETRY; PENICILLIUM CHRYSOGENUM; PROTON NUCLEAR MAGNETIC RESONANCE; STAPHYLOCOCCUS AUREUS;

EID: 84858325574     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Tripathi KD. Essentials of medical pharmacology. First ed. Jaypee brothers publication (P), LTD, New Delhi; 226-238.
2. Todar K. Pathogenic E. coli. Online Textbook of Bacteriology. University of Wisconsin-Madison Department of Bacteriology. 2007; 11-30.
3. http://en.wikipedia.org/wiki/Staphylococcus_aureus
4. Arias ME, Gomez JD, Cudmani NM, Vattuone MA and Isla MI. Antibacterial activity of ethanolic and aqueous extracts of Acacia aroma Gill Ex Hook et. Arn. Life Sci. 2004; 75: 191-202.
5. Sharath N, Halehatty S, Bhojya VN, Kumar V and Hoskeri J. Antibacterial, Molecular Docking, DNA Binding and Photocleavage Studies on Novel Heterocyclic Pyrazoles. British J. Pharm. Res. 2011; 1(2): 46-65, 57.
6. Betoni JEC, Mantovani RP and Barbosa, LN. Synergism between plant extract and antimicrobial drugs used on Staphylococcus aureus diseases. Memo' rias do Instituto Oswaldo, Rio de Janeiro. 2006; 101: 2387-390.
7. http://www.pillwatch.com/info/otc-antifungal-medications.html
8. Shen HD, Chou H, Tam MF, Chang CY, Lai HY and Wang SR. Molecular and immunological characterization of Pen ch 18, the vacuolar serine protease major allergen of Penicillium chrysogenum. Allergy. 2003; 58(10): 993-1002.
9. Sharma A, Patel VK, Rawat S, Ramteke P and Verma R. Identification of the antibacterial component of some Indian medicinal Plants against Klebsiella Pneumoniae. Int J Pharmacy and Pharm Sci. 2010; (2)3: 123-127.
10. Qureshi AA, Omer S, Kumar KE and Bhajipale NS. Probiotics In Diarrhea: Myths And Facts. 2010; 2(3): 24.
11. Neu HC. The crisis in antibiotic resistance. Science. 1992; 257: 1064.
12. http://www.can-r.com/mediaResources/Azoles.pdf
13. Patel VM and Desai KR. Eco-Friendly Synthesis Of Fluorine-Containing Pyrazoline Derivatives Over Potassium Carbonate. KIVOC. 2004; I: 123-129.
14. Abunada NM, Hassaneen HM, Kandile NG and Miqdad OA. Synthesis and Antimicrobial Activity of Some New Pyrazole Fused Pyrazolo[3,4-d]-pyrimidine and Pyrazolo[4,3-e][1,2,4]-triazolo[1,5-c]pyrimidine Derivatives. Molecules. 2008; 13: 1501-1517.
15. Jungheim LN, Holmes RE, Ott JL, Ternansky RJ, Draheim SE, Neel DA, Stepherd TA and Sigmund SK. Antimicrobial Agents and Chemotherapy, Presented at 26th Interscience conference, New Orleans, LA. 1998; Sept.28-Oct.1: Paper 601.
16. Jungheim LN, Holmes RE, Ternansky RJ, Stepherd TA, Neel DA, Draheim, SE, Pike AJ and Wu CYE. Antimicrobial Agents and chemotherapy, Presented at 28th Interscience conference Los Angels, CA, 1998; Oct 23-26: Paper 240. 12.
17. Gomes A, Fernandes E, Garacia MB, Silva AM, Pinto DC, Santo CM, Cavalerio JA and Lima JL. Cyclic voltametric analysis of 2-styrylchromenes; relationship with antioxidant activity. Bioorg. Med. Chem. 2008; 16: 7939-7943.
18. Schmidt JG. Ber. Dtsch Chem. Ges. 1880; 13: 2342.
19. Claisen L, Claparede A. Ber. Dtsch. Chem. Ges. 1881; 14: 349.
20. Kohler EP, Chadwell HM. Org. Synth. 1922; 2: 1.
21. Pereira CMP, Quina FH, Silva FAN, Emmerich DJ and Machulek A. Synthesis Of 4-Iodopyrazoles: A Brief Review. Bentham Science Publishers Ltd. 2008; 5: 331-335.
22. Tripathi KD. Essentials of medical pharmacology. 1st ed.; Jaypee brothers publication (P), LTD, New Delhi, 226-238.
23. Fraley ME, Hoffman WF, Rubino RS, Hungate RW, Tebbon AJ, Rutledge RZ, McFall RC, Huckle WR, Kendall RL, Coll KE and Thomas KA. Bioorg. Med. Chem. Lett. 2002; 12: 2767.
24. Huang Y, Hu X, Shen D, Chen Y and Xu P. Mol. Divers. 2007; 11: 73.
25. Wilson WL and Bottiglieri NG. Cancer Chemother. Rep.1962; Part 1: 137.
26. Aziz MA, El-Din A G. Abuo-Rahma and Alaa A. Hassan. Synthesis of novel pyrazole derivatives and evaluation of their antidepressant and anticonvulsant activities. Euro J Med. Chem. 2009; 44(9): 3480-3487.
27. Dawane BS, Konda SG, Shaikh BM, Chobe SS, Khandare NT, Kamble VT and Bhosale RB. Synthesis and In Vitro Antimicrobial Activity Of Some New 1-Thiazolyl-2-Pyrazoline Derivatives. 2010; 1(2): 342.
28. Hu H, Ge C, Ding L and Zhang A. Synthesis of Novel 1-[(2,6-Dichloro-4-trifluoromethyl)phenyl]-3-aryl-1H-pyrazole-4-carbaldehydes. Molecules. 2010; 15: 7472-7481.
29. http://www.chemyq.com/patentfmen/pt5/46017_4D602.htm
30. Lamani RS, Kumar N, Shetty S, Ravindra R, Kamble and Khazi M IA. Synthesis and antimicrobial studies of novel methylene bridged bezisoxazolyl imidazol[2,1-b] [1,3,4]thiadiazole derivatives. Eur. J. Med. Chem. 2009; 44: 2823-2833.
31. Kulkarni SK. Handbook of Experimental Pharmacology, Vallabh Prakashan, 1999; 3: 123-131.
32. Collins AH. Microbiological Methods, London Butterworth, 1976; 3: 2.
33. http://en.wikipedia.org/wiki/Potato_dextrose_agar
34. The United States pharmacopeia, 31st ed., Amended Chapters 61, 62, 111. The United States Pharmacopeial Convention. 2007. Rockville, MD.
35. Directorate for the Quality of Medicines of the Council of Europe (EDQM). 2007. The European Pharmacopoeia, Amended Chapters 2.6.12, 2.6.13, 5.1.4, Council of Europe, 67075 Strasbourg Cedex, France.
36. The Minister of Health, Labor, and Welfare. Japanese Pharmacopoeia 2007. Society of Japanese Pharmacopoeia. Amended Chapters 35.1, 35.2, 7.
37. Arias ME, Gomez JD, Cudmani NM, Vattuone MA and Isla MI. Antibacterial activity of ethanolic and aqueous extracts of Acacia aroma Gill. Ex Hook et Arn. Life Sci, 2004; 75: 191-202.
38. Sharath N, Halehatty S, Bhojya VN, Kumar V and Hoskeri J. Antibacterial, Molecular Docking, DNA Binding and Photocleavage Studies on Novel Heterocyclic Pyrazoles. British J. Pharm. Res. 2011; 1(2): 46-65,57.
39. Betoni JEC, Mantovani RP and Barbosa LN. Synergism between plant extract and antimicrobial drugs used on Staphylococcus aureus diseases. Memo' rias do Instituto Oswaldo, Rio de Janeiro. 2006; 101: 387-390.
40. Nikaido V. Molecular basis of bacterial outer membrane permeability. Microbiol. 1985; 1: 1-32.